Home Stock

Stock Research: Steris

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Steris

NYQ:STE IE00BFY8C754
46
  • Value
    35
  • Growth
    60
  • Safety
    Safety
    80
  • Combined
    58
  • Sentiment
    33
  • 360° View
    360° View
    46
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

STERIS Plc provides products and services focused on infection prevention. It operates in Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The company serves healthcare providers worldwide, medical device and pharmaceutical manufacturers globally, and biopharmaceutical and medical device research and manufacturing facilities. In the last fiscal year, the company had a market cap of $22,511 million, profits of $2,403 million, revenue of $5,460 million, and 17,787 employees.

more

ANALYSIS: With an Obermatt 360° View of 46 (better than 46% compared with alternatives), overall professional sentiment and financial characteristics for the stock Steris are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Steris. The consolidated Growth Rank has a good rank of 60, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 60% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 80 which means that the company has a financing structure that is safer than 80% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 35 which means that the share price of Steris is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 65% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 33, which means that professional investors are more pessimistic about the stock than for 67% of alternative investment opportunities. ...read more

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Pro Holdings
Country Ireland
Industry Health Care Equipment
Size X-Large
Website steris.com
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Steris stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
35 22 29 43
Growth
60 76 87 67
Safety
Safety
80 26 15 41
Sentiment
33 40 63 87
360° View
360° View
46 28 53 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
27 65 78 90
Opinions Change
14 23 29 50
Pro Holdings
n/a 65 64 86
Market Pulse
33 21 42 24
Sentiment
33 40 63 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
35 22 29 43
Growth
60 76 87 67
Safety Safety
80 26 15 41
Combined
58 23 25 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
34 23 28 33
Price vs. Earnings (P/E)
13 41 42 36
Price vs. Book (P/B)
31 34 34 56
Dividend Yield
67 39 40 42
Value
35 22 29 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
57 45 55 56
Profit Growth
92 36 57 58
Capital Growth
30 89 62 51
Stock Returns
51 60 83 63
Growth
60 76 87 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
59 36 38 52
Refinancing
57 17 33 35
Liquidity
87 42 30 47
Safety Safety
80 26 15 41

Similar Stocks

Discover high‑ranked alternatives to Steris and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Alcon

VTX:ALC
Country: Switzerland
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

Glenveagh Properties

ISE:GVR
Country: Ireland
Industry: Homebuilding
Size: Medium
Full Stock Analysis

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews